Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Clin Lung Cancer

Retrieve available abstracts of 179 articles:
HTML format
Text format



Single Articles


    February 2017
  1. HOW J, Mann J, Laczniak AN, Baggstrom MQ, et al
    Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
    Clin Lung Cancer. 2017 Feb 9. pii: S1525-7304(17)30042.
    PubMed     Text format     Abstract available


  2. SHIRAN I, Heller E, Jessel S, Kamer I, et al
    Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
    Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30038.
    PubMed     Text format     Abstract available


  3. JACOBS CD, Jafari ME
    Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-dose CT at a Community Hospital.
    Clin Lung Cancer. 2017 Feb 2. pii: S1525-7304(17)30040.
    PubMed     Text format     Abstract available


    January 2017
  4. NGUYEN NA, Isfahanian N, Pond G, Hanna W, et al
    A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).
    Clin Lung Cancer. 2017 Jan 31. pii: S1525-7304(17)30036.
    PubMed     Text format     Abstract available


  5. JANSSENS A, Derijcke S, Lefebure A, Vandenbroucke E, et al
    Addressing the Palliative Setting in Advanced Lung Cancer Should Not Remain a Barrier: A Multicenter Study.
    Clin Lung Cancer. 2017 Jan 20. pii: S1525-7304(17)30001.
    PubMed     Text format     Abstract available


  6. NIEDER C, Tollali T, Haukland E, Reigstad A, et al
    External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2017 Jan 19. pii: S1525-7304(17)30021.
    PubMed     Text format     Abstract available


  7. DINGLIN XX, Ma SX, Wang F, Li DL, et al
    Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
    Clin Lung Cancer. 2017 Jan 13. pii: S1525-7304(16)30392.
    PubMed     Text format     Abstract available


  8. RAPHAEL J, Chan K, Karim S, Kerbel R, et al
    Antiangiogenic Therapy in Advanced Non-small-cell Lung Cancer: A Meta-analysis of Phase III Randomized Trials.
    Clin Lung Cancer. 2017 Jan 12. pii: S1525-7304(17)30004.
    PubMed     Text format     Abstract available


  9. PARK CK, Oh IJ, Kim KS, Choi YD, et al
    Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non-Small-cell Lung Cancer: A TRAIL Trial.
    Clin Lung Cancer. 2017 Jan 11. pii: S1525-7304(17)30002.
    PubMed     Text format     Abstract available


  10. SOCINSKI MA, Chaft JE, Levy B, Riely GJ, et al
    The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30377.
    PubMed     Text format    


  11. SUNG MR, Patel MV, Djalalov S, Le LW, et al
    Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30386.
    PubMed     Text format     Abstract available


  12. REMICK JS, Schonewolf C, Gabriel P, Doucette A, et al
    First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2017 Jan 5. pii: S1525-7304(16)30385.
    PubMed     Text format     Abstract available


    December 2016
  13. JIANG T, Qiao M, Zhou F, Ren S, et al
    Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non-Small-cell Lung Cancer on Progression-free and Overall Survival.
    Clin Lung Cancer. 2016 Dec 29. pii: S1525-7304(16)30388.
    PubMed     Text format     Abstract available


  14. LIN YT, Liu YN, Wu SG, Yang JC, et al
    Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 28. pii: S1525-7304(16)30390.
    PubMed     Text format     Abstract available


  15. LABBE C, Leung Y, Silva Lemes JG, Stewart E, et al
    Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy.
    Clin Lung Cancer. 2016 Dec 28. pii: S1525-7304(16)30391.
    PubMed     Text format     Abstract available


  16. LIM YJ, Chang JH, Kim HJ, Keam B, et al
    Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Clin Lung Cancer. 2016 Dec 28. pii: S1525-7304(16)30389.
    PubMed     Text format     Abstract available


  17. GANDARA DR, Riess JW, Kelly K, Li T, et al
    Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 24. pii: S1525-7304(16)30387.
    PubMed     Text format     Abstract available


  18. SABA NF, Wang Y, Fu H, Koenig L, et al
    Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30381.
    PubMed     Text format     Abstract available


  19. LI KL, Li L, Zhang P, Kang J, et al
    A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30379.
    PubMed     Text format     Abstract available


  20. TEMBHEKAR AR, Wright CL, Daly ME
    Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30383.
    PubMed     Text format     Abstract available


  21. POST CM, Verma V, Mitin T, Simone CB 2nd, et al
    Practice Patterns of Thoracic Radiotherapy for Extensive-Stage Small-Cell Lung Cancer: Survey of US Academic Thoracic Radiation Oncologists.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30380.
    PubMed     Text format     Abstract available


  22. WEISS J, Force RW, Pugmire BA, Peterson T, et al
    Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non-Small-cell Lung Cancer in a US Community Oncology Setting.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30384.
    PubMed     Text format     Abstract available


  23. SAKAKIBARA R, Inamura K, Tambo Y, Ninomiya H, et al
    EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer.
    Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30378.
    PubMed     Text format     Abstract available


  24. PETERSON J, Niles C, Patel A, Boujaoude Z, et al
    Stereotactic Body Radiotherapy for Large (> 5 cm) Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 8. pii: S1525-7304(16)30374.
    PubMed     Text format     Abstract available


  25. LYNCH JA, Berse B, Chun D, Rivera D, et al
    Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs.
    Clin Lung Cancer. 2016 Dec 7. pii: S1525-7304(16)30372.
    PubMed     Text format     Abstract available


  26. ASAO T, Fujiwara Y, Itahashi K, Kitahara S, et al
    Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
    Clin Lung Cancer. 2016 Dec 7. pii: S1525-7304(16)30369.
    PubMed     Text format     Abstract available


  27. BERNHARDT D, Adeberg S, Bozorgmehr F, Opfermann N, et al
    Nine-year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 2. pii: S1525-7304(16)30366.
    PubMed     Text format     Abstract available


  28. BALDI M, Behera D, Kaur J, Kapoor R, et al
    Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B12 and Folate Supplementation in Nonsquamous, Non-Small-cell Lung Cancer Patients Undergoing First-line Pemetrexed-based
    Clin Lung Cancer. 2016 Dec 2. pii: S1525-7304(16)30371.
    PubMed     Text format     Abstract available


  29. SCHNEIDER BJ, Kalemkerian GP, Gadgeel SM, Valdivieso M, et al
    Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 2. pii: S1525-7304(16)30373.
    PubMed     Text format     Abstract available


  30. ISAKA M, Serizawa M, Kenmotsu H, Koh Y, et al
    Comparison of Clinically Relevant Mutation Profiles Between Preoperative Biopsy and Corresponding Surgically Resected Specimens in Japanese Patients With Non-Small-cell Lung Cancer by Amplicon-based Massively Parallel Sequencing.
    Clin Lung Cancer. 2016 Dec 2. pii: S1525-7304(16)30376.
    PubMed     Text format     Abstract available


  31. HITIJ NT, Kern I, Sadikov A, Knez L, et al
    Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Dec 2. pii: S1525-7304(16)30375.
    PubMed     Text format     Abstract available


    November 2016
  32. GAUTSCHI O, Rothschild SI, Li Q, Matter-Walstra K, et al
    Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
    Clin Lung Cancer. 2016 Nov 23. pii: S1525-7304(16)30361.
    PubMed     Text format     Abstract available


  33. LARA MS, Holland WS, Chinn D, Burich RA, et al
    Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Nov 21. pii: S1525-7304(16)30360.
    PubMed     Text format     Abstract available


  34. HO QA, Harandi NK, Daly ME
    Clinical Impact of Frequent Surveillance Imaging in the First Year Following Chemoradiation for Locally Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Nov 21. pii: S1525-7304(16)30364.
    PubMed     Text format     Abstract available


  35. EZE C, Roengvoraphoj O, Niyazi M, Hildebrandt G, et al
    Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.
    Clin Lung Cancer. 2016 Nov 21. pii: S1525-7304(16)30359.
    PubMed     Text format     Abstract available


  36. SHEN C, Kehl KL, Zhao B, Simon GR, et al
    Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.
    Clin Lung Cancer. 2016 Nov 11. pii: S1525-7304(16)30355.
    PubMed     Text format     Abstract available


  37. PERVERE LM, Rakshit S, Schrock AB, Miller VA, et al
    Durable Response to Combination of Dabrafenib and Trametinib in BRAF V600E-Mutated Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Nov 11. pii: S1525-7304(16)30354.
    PubMed     Text format    


  38. REDDY JP, Tang C, Shih T, Kim B, et al
    Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Nov 10. pii: S1525-7304(16)30356.
    PubMed     Text format     Abstract available


  39. SANTARPIA M, Ramirez JL, de Aguirre I, Garrido P, et al
    Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
    Clin Lung Cancer. 2016 Nov 9. pii: S1525-7304(16)30242.
    PubMed     Text format     Abstract available


    October 2016
  40. SARFATY M, Moore A, Neiman V, Dudnik E, et al
    RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.
    Clin Lung Cancer. 2016 Oct 29. pii: S1525-7304(16)30228.
    PubMed     Text format     Abstract available


  41. LA SALVIA A, Rossi A, Galetta D, Gobbini E, et al
    Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis.
    Clin Lung Cancer. 2016 Oct 28. pii: S1525-7304(16)30240.
    PubMed     Text format     Abstract available


  42. LI T, Piperdi B, Walsh WV, Kim M, et al
    Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 28. pii: S1525-7304(16)30346.
    PubMed     Text format     Abstract available


  43. FALKSON CB, Vella ET, Yu E, El-Mallah M, et al
    Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2016 Oct 27. pii: S1525-7304(16)30351.
    PubMed     Text format     Abstract available


  44. GIRARD N, Corral J, Cortinovis D, Heigener DF, et al
    Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.
    Clin Lung Cancer. 2016 Oct 26. pii: S1525-7304(16)30347.
    PubMed     Text format     Abstract available


  45. JAKUBOWSKI CD, Plodkowski AJ, Chang JC, Rekhtman N, et al
    Successful Use of Afatinib After Erlotinib-induced Pneumonitis in a Patient With Epidermal Growth Factor Receptor-mutant Lung Cancer.
    Clin Lung Cancer. 2016 Oct 26. pii: S1525-7304(16)30344.
    PubMed     Text format    


  46. BAGLEY SJ, Vitale S, Zhang S, Aggarwal C, et al
    Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 26. pii: S1525-7304(16)30353.
    PubMed     Text format     Abstract available


  47. GERBER DE, Urbanic JJ, Langer C, Hu C, et al
    Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505).
    Clin Lung Cancer. 2016 Oct 26. pii: S1525-7304(16)30352.
    PubMed     Text format     Abstract available


  48. ZER A, Moskovitz M, Hwang DM, Hershko-Klement A, et al
    ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
    Clin Lung Cancer. 2016 Oct 26. pii: S1525-7304(16)30350.
    PubMed     Text format     Abstract available


  49. OKUMA HS, Horinouchi H, Kitahara S, Asao T, et al
    Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 25. pii: S1525-7304(16)30230.
    PubMed     Text format     Abstract available


  50. NINOMIYA K, Ichihara E, Hotta K, Sone N, et al
    Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
    Clin Lung Cancer. 2016 Oct 19. pii: S1525-7304(16)30223.
    PubMed     Text format     Abstract available


  51. WAKELEE H, Zvirbule Z, De Braud F, Kingsley CD, et al
    Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 19. pii: S1525-7304(16)30241.
    PubMed     Text format     Abstract available


  52. LAFUENTE-SANCHIS A, Zuniga A, Estors M, Martinez-Hernandez NJ, et al
    Association of PD-1, PD-L1, and CTLA-4 Gene Expression and Clinicopathologic Characteristics in Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 17. pii: S1525-7304(16)30236.
    PubMed     Text format     Abstract available


  53. GAO SJ, Corso CD, Blasberg JD, Detterbeck FC, et al
    Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall.
    Clin Lung Cancer. 2016 Oct 17. pii: S1525-7304(16)30239.
    PubMed     Text format     Abstract available


  54. SJOBLOM B, Benth JS, Gronberg BH, Baracos VE, et al
    Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Oct 5. pii: S1525-7304(16)30234.
    PubMed     Text format     Abstract available


  55. PAULSEN EE, Kilvaer TK, Khanehkenari MR, Al-Saad S, et al
    Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
    Clin Lung Cancer. 2016 Oct 5. pii: S1525-7304(16)30235.
    PubMed     Text format     Abstract available


  56. JUNG YJ, Katilius E, Ostroff RM, Kim Y, et al
    Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
    Clin Lung Cancer. 2016 Oct 5. pii: S1525-7304(16)30238.
    PubMed     Text format     Abstract available


  57. BECKER DJ, Wisnivesky JP, Grossbard ML, Chachoua A, et al
    Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy.
    Clin Lung Cancer. 2016 Oct 5. pii: S1525-7304(16)30243.
    PubMed     Text format     Abstract available


  58. SWAMINATH A, Wierzbicki M, Parpia S, Wright JR, et al
    Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Gr
    Clin Lung Cancer. 2016 Oct 3. pii: S1525-7304(16)30224.
    PubMed     Text format     Abstract available


    August 2016
  59. LEIGHL NB, Rizvi NA, de Lima LG Jr, Arpornwirat W, et al
    Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2016 Aug 8. pii: S1525-7304(16)30187.
    PubMed     Text format     Abstract available


  60. WONG AT, Rineer J, Schwartz D, Becker D, et al
    Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.
    Clin Lung Cancer. 2016 Aug 8. pii: S1525-7304(16)30189.
    PubMed     Text format     Abstract available


    July 2016
  61. ZAKI M, Dominello M, Dyson G, Gadgeel S, et al
    Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jul 22. pii: S1525-7304(16)30185.
    PubMed     Text format     Abstract available


  62. LOKHANDWALA T, Bittoni MA, Dann RA, D'Souza AO, et al
    Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.
    Clin Lung Cancer. 2016 Jul 21. pii: S1525-7304(16)30186.
    PubMed     Text format     Abstract available


  63. BRADBURY P, Sivajohanathan D, Chan A, Kulkarni S, et al
    Postoperative Adjuvant Systemic Therapy in Completely Resected Non-Small-Cell Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2016 Jul 12. pii: S1525-7304(16)30181.
    PubMed     Text format     Abstract available


  64. ODA N, Ichihara E, Hotta K, Ninomiya K, et al
    Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403.
    Clin Lung Cancer. 2016 Jul 9. pii: S1525-7304(16)30182.
    PubMed     Text format     Abstract available


  65. WONG KM, Ding K, Li S, Bradbury P, et al
    A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jul 9. pii: S1525-7304(16)30149.
    PubMed     Text format     Abstract available


  66. OHASHI K, Hotta K, Hirata T, Aoe K, et al
    Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non-Small-Cell Lung Cancer: Study Protocol.
    Clin Lung Cancer. 2016 Jul 9. pii: S1525-7304(16)30184.
    PubMed     Text format     Abstract available


  67. LEE JW, Na JO, Kang DY, Lee SY, et al
    Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Clin Lung Cancer. 2016 Jul 9. pii: S1525-7304(16)30180.
    PubMed     Text format     Abstract available


  68. CHAE YK, Pan A, Davis AA, Mohindra N, et al
    Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jul 9. pii: S1525-7304(16)30183.
    PubMed     Text format     Abstract available


  69. TOROK JA, Gu L, Tandberg DJ, Wang X, et al
    Patterns of Distant Metastases After Surgical Management of Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Jul 5. pii: S1525-7304(16)30169.
    PubMed     Text format     Abstract available


  70. DALY ME, Lara PN Jr
    Local Radiation for Extensive Stage Small Cell Lung Cancer: A Step Forward or Running in Place?
    Clin Lung Cancer. 2016;17:237-8.
    PubMed     Text format    


    June 2016
  71. CHOI M, Lee Y, Moon SH, Han JY, et al
    Effect of Accurate Staging Using Positron Emission Tomography on the Outcomes of Prophylactic Cranial Irradiation in Patients With Limited Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 29. pii: S1525-7304(16)30178.
    PubMed     Text format     Abstract available


  72. KHANNA P, Blais N, Gaudreau PO, Corrales-Rodriguez L, et al
    Immunotherapy Comes of Age in Lung Cancer.
    Clin Lung Cancer. 2016 Jun 25. pii: S1525-7304(16)30146.
    PubMed     Text format     Abstract available


  73. MURTON AJ, Maddocks M, Stephens FB, Marimuthu K, et al
    Consequences of Late-Stage Non-Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes.
    Clin Lung Cancer. 2016 Jun 25. pii: S1525-7304(16)30143.
    PubMed     Text format     Abstract available


  74. JOHNSON MD, Sura K, Mangona VS, Glick A, et al
    Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 23. pii: S1525-7304(16)30144.
    PubMed     Text format     Abstract available


  75. KIM YH, Lee WK, Lee EB, Son JW, et al
    Combined Effect of Metastasis-Related MicroRNA, miR-34 and miR-124 Family, Methylation on Prognosis of Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 23. pii: S1525-7304(16)30145.
    PubMed     Text format     Abstract available


  76. GAO HF, Li AN, Yang JJ, Chen ZH, et al
    Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 23. pii: S1525-7304(16)30148.
    PubMed     Text format     Abstract available


  77. SARUWATARI K, Umemura S, Nomura S, Kirita K, et al
    Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy.
    Clin Lung Cancer. 2016 Jun 16. pii: S1525-7304(16)30138.
    PubMed     Text format     Abstract available


  78. SHEIKINE Y, Rangachari D, McDonald DC, Huberman MS, et al
    EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30132.
    PubMed     Text format     Abstract available


  79. CHU BF, Otterson GA
    Incorporation of Antiangiogenic Therapy Into the Non-Small-Cell Lung Cancer Paradigm.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30136.
    PubMed     Text format     Abstract available


  80. YANG KL, Chang YC, Ko HL, Chi MS, et al
    Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30129.
    PubMed     Text format     Abstract available


  81. MCCOACH CE, Bivona TG, Blakely CM, Doebele RC, et al
    Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30141.
    PubMed     Text format     Abstract available


  82. POLLOM EL, Qian Y, Durkee BY, von Eyben R, et al
    Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30140.
    PubMed     Text format     Abstract available


  83. DAWE DE, Pond GR, Ellis PM
    Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30128.
    PubMed     Text format     Abstract available


  84. MATIKAS A, Syrigos KN, Agelaki S
    Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30137.
    PubMed     Text format     Abstract available


  85. PORE M, Meijer C, de Bock GH, Boersma-van Ek W, et al
    Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30131.
    PubMed     Text format     Abstract available


  86. GARON EB, Reck M, Paz-Ares L, Ponce S, et al
    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 8. pii: S1525-7304(16)30139.
    PubMed     Text format     Abstract available


  87. RAEZ LE, Santos ES, Rolfo C, Lopes G, et al
    Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America.
    Clin Lung Cancer. 2016 Jun 5. pii: S1525-7304(16)30108.
    PubMed     Text format     Abstract available


  88. CATANIA C, Passaro A, Rocco EG, Spitaleri G, et al
    Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
    Clin Lung Cancer. 2016 Jun 4. pii: S1525-7304(16)30109.
    PubMed     Text format    


  89. HIRSCH FR, Govindan R, Zvirbule Z, Braiteh F, et al
    Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 4. pii: S1525-7304(16)30116.
    PubMed     Text format     Abstract available


  90. SCHULKES KJ, Hamaker ME, van den Bos F, van Elden LJ, et al
    Relevance of a Geriatric Assessment for Elderly Patients With Lung Cancer-A Systematic Review.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30112.
    PubMed     Text format     Abstract available


  91. ROVIELLO G, Zanotti L, Cappelletti MR, Gobbi A, et al
    No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30113.
    PubMed     Text format     Abstract available


  92. RADES D, Kasmann L, Schild SE, Janssen S, et al
    A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30115.
    PubMed     Text format     Abstract available


  93. MATIKAS A, Kentepozidis N, Georgoulias V, Kotsakis A, et al
    Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30111.
    PubMed     Text format     Abstract available


  94. ISOZAKI H, Hotta K, Ichihara E, Takigawa N, et al
    Protocol Design for the Bench to Bed Trial in Alectinib-Refractory Non-Small-Cell Lung Cancer Patients Harboring the EML4-ALK Fusion Gene (ALRIGHT/OLCSG1405).
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30110.
    PubMed     Text format     Abstract available


  95. KARAMPEAZIS A, Vamvakas L, Kentepozidis N, Polyzos A, et al
    Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
    Clin Lung Cancer. 2016 Jun 2. pii: S1525-7304(16)30114.
    PubMed     Text format     Abstract available


    May 2016
  96. WATANABE S, Hayashi H, Okamoto K, Fujiwara K, et al
    Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.
    Clin Lung Cancer. 2016 May 18. pii: S1525-7304(16)30106.
    PubMed     Text format     Abstract available


  97. AIETA M, Facchinetti A, De Faveri S, Manicone M, et al
    Monitoring and Characterization of Circulating Tumor Cells (CTCs) in a Patient With EML4-ALK-Positive Non-Small Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2016 May 18. pii: S1525-7304(16)30107.
    PubMed     Text format    


  98. BERRIOCHOA C, Videtic GM, Woody NM, Djemil T, et al
    Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion.
    Clin Lung Cancer. 2016 May 10. pii: S1525-7304(16)30067.
    PubMed     Text format     Abstract available


  99. KERRIGAN K, Shoben A, Otterson G
    Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit.
    Clin Lung Cancer. 2016 May 5. pii: S1525-7304(16)30064.
    PubMed     Text format     Abstract available


  100. GERBER DE, Spigel DR, Giorgadze D, Shtivelband M, et al
    Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016;17:169-76.
    PubMed     Text format     Abstract available


    April 2016
  101. LU S, Cheng Y, Zhou CC, Wang J, et al
    Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Apr 29. pii: S1525-7304(16)30063.
    PubMed     Text format     Abstract available


  102. HIRSH V, Ko A, Pilot R, Renschler MF, et al
    Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes.
    Clin Lung Cancer. 2016 Apr 22. pii: S1525-7304(16)30062.
    PubMed     Text format     Abstract available


  103. GRIDELLI C, Rossi A, Ciardiello F, De Marinis F, et al
    BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Apr 22. pii: S1525-7304(16)30061.
    PubMed     Text format     Abstract available


  104. CHAE YK, Pan A, Davis AA, Raparia K, et al
    Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
    Clin Lung Cancer. 2016 Apr 6. pii: S1525-7304(16)30057.
    PubMed     Text format     Abstract available


    March 2016
  105. GAO X, VanderLaan PA, Bailey AS, Costa DB, et al
    Comprehensive Genomic Profiling Differentiates Metachronous Primary Small-Cell Lung Cancer From Late Recurrence.
    Clin Lung Cancer. 2016 Mar 30. pii: S1525-7304(16)30035.
    PubMed     Text format    


  106. WU FZ, Huang YL, Wu CC, Tang EK, et al
    Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Clin Lung Cancer. 2016 Mar 30. pii: S1525-7304(16)30033.
    PubMed     Text format     Abstract available


  107. WU GX, Raz DJ, Brown L, Sun V, et al
    Psychological Burden Associated With Lung Cancer Screening: A Systematic Review.
    Clin Lung Cancer. 2016 Mar 30. pii: S1525-7304(16)30053.
    PubMed     Text format     Abstract available


  108. LIN YT, Yu CJ, Yang JC, Shih JY, et al
    Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review.
    Clin Lung Cancer. 2016 Mar 30. pii: S1525-7304(16)30034.
    PubMed     Text format     Abstract available


  109. XIE P, Li X, Tan X, Sun X, et al
    Sequential Serum Let-7 Is a Novel Biomarker to Predict Accelerated Reproliferation During Fractional Radiotherapy in Lung Cancer.
    Clin Lung Cancer. 2016 Mar 29. pii: S1525-7304(16)30056.
    PubMed     Text format     Abstract available


  110. MCKAY C, Burke T, Cao X, Abernethy AP, et al
    Treatment Patterns for Advanced Non-Small-cell Lung Cancer After Platinum-containing Therapy in U.S. Community Oncology Clinical Practice.
    Clin Lung Cancer. 2016 Mar 29. pii: S1525-7304(16)30054.
    PubMed     Text format     Abstract available


  111. SATOH H, Tamura T, Kawaguchi M, Ishiakwa H, et al
    CT Characteristics and Survival in Lung Adenocarcinoma.
    Clin Lung Cancer. 2016;17:e23.
    PubMed     Text format    


    February 2016
  112. ZENKE Y, Yoh K, Matsumoto S, Umemura S, et al
    Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
    Clin Lung Cancer. 2016 Feb 5. pii: S1525-7304(16)30003.
    PubMed     Text format     Abstract available


  113. JEGADEESH N, Liu Y, Gillespie T, Fernandez F, et al
    Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.
    Clin Lung Cancer. 2016 Feb 2. pii: S1525-7304(16)30004.
    PubMed     Text format     Abstract available


  114. KIM IH, Lee IH, Lee JE, Hong SH, et al
    Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Feb 2. pii: S1525-7304(16)30002.
    PubMed     Text format     Abstract available


    January 2016
  115. GRIDELLI C, Besse B, Brahmer JR, Crino L, et al
    The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
    Clin Lung Cancer. 2016 Jan 28. pii: S1525-7304(16)30001.
    PubMed     Text format     Abstract available


  116. WU GX, Goldstein L, Kim JY, Raz DJ, et al
    Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Clin Lung Cancer. 2016 Jan 14. pii: S1525-7304(16)00004.
    PubMed     Text format     Abstract available


  117. DZIEDZIC DA, Rudzinski P, Langfort R, Orlowski T, et al
    Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2016 Jan 11. pii: S1525-7304(16)00003.
    PubMed     Text format     Abstract available


  118. BEZEL P, Tischler V, Robinson C, Baumueller S, et al
    Diagnostic Value of Bronchoalveolar Lavage for Diagnosis of Suspected Peripheral Lung Cancer.
    Clin Lung Cancer. 2016 Jan 9. pii: S1525-7304(16)00002.
    PubMed     Text format     Abstract available


  119. CAO Y, Liu Y, Yang X, Liu X, et al
    Estimation of the Survival of Patients With Lung Squamous Cell Carcinoma Using Genomic Copy Number Aberrations.
    Clin Lung Cancer. 2016;17:68-74.
    PubMed     Text format     Abstract available


  120. SAHNANE N, Frattini M, Bernasconi B, Zappa F, et al
    EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
    Clin Lung Cancer. 2016;17:56-61.
    PubMed     Text format     Abstract available


    December 2015
  121. JANNE PA, Mann H, Ghiorghiu D
    Study Design and Rationale for a Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Selumetinib in Combination With Docetaxel as Second-Line Treatment in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cance
    Clin Lung Cancer. 2015 Dec 30. pii: S1525-7304(15)00304.
    PubMed     Text format     Abstract available


  122. GOTFRIT J, Zhang T, Zanon-Heacock S, Wheatley-Price P, et al
    Patients With Advanced Non-Small Cell Lung Cancer Requiring Inpatient Medical Oncology Consultation: Characteristics, Referral Patterns, and Outcomes.
    Clin Lung Cancer. 2015 Dec 30. pii: S1525-7304(15)00305.
    PubMed     Text format     Abstract available


  123. CHEN H, Louie AV, Boldt RG, Rodrigues GB, et al
    Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2015 Dec 22. pii: S1525-7304(15)00303.
    PubMed     Text format     Abstract available


  124. BRADE A, MacRae R, Laurie SA, Bezjak A, et al
    Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2015 Dec 21. pii: S1525-7304(15)00302.
    PubMed     Text format     Abstract available


  125. MYALL NJ, Neal JW, Cho-Phan CD, Zhou LY, et al
    Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.
    Clin Lung Cancer. 2015 Dec 18. pii: S1525-7304(15)00295.
    PubMed     Text format    


  126. GIROUX LEPRIEUR E, Vieira T, Antoine M, Rozensztajn N, et al
    Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Carcinoma.
    Clin Lung Cancer. 2015 Dec 17. pii: S1525-7304(15)00301.
    PubMed     Text format     Abstract available


  127. ZHOU C, Huang Y, Wang D, An C, et al
    A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), A Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC).
    Clin Lung Cancer. 2015 Dec 17. pii: S1525-7304(15)00296.
    PubMed     Text format     Abstract available


  128. GIULIANI J, Bonetti A
    Pharmacologic Costs of Tyrosine Kinase Inhibitors in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations: A Review of Pivotal Phase III Randomized Controlled Trials.
    Clin Lung Cancer. 2015 Dec 17. pii: S1525-7304(15)00299.
    PubMed     Text format    


  129. WEISS JM, Villaruz LC, O'Brien J, Ivanova A, et al
    Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer.
    Clin Lung Cancer. 2015 Dec 17. pii: S1525-7304(15)00300.
    PubMed     Text format     Abstract available


  130. BOYE M, Wang X, Srimuninnimit V, Kang JH, et al
    First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results From a
    Clin Lung Cancer. 2015 Dec 17. pii: S1525-7304(15)00298.
    PubMed     Text format     Abstract available


  131. GRAY EP, Teare MD, Stevens J, Archer R, et al
    Risk Prediction Models for Lung Cancer: A Systematic Review.
    Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00271.
    PubMed     Text format     Abstract available


  132. ULIVI P, Chiadini E, Dazzi C, Dubini A, et al
    Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
    Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00268.
    PubMed     Text format     Abstract available


  133. HAN JJ, Kim DW, Koh J, Keam B, et al
    Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00270.
    PubMed     Text format     Abstract available


  134. XU J, Chu T, Jin B, Dong X, et al
    Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung Cancer.
    Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00273.
    PubMed     Text format     Abstract available


  135. GANTI AK, Shostrom V, Alorabi M, Zhen WK, et al
    Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database Analysis.
    Clin Lung Cancer. 2015 Dec 1. pii: S1525-7304(15)00278.
    PubMed     Text format     Abstract available


    November 2015
  136. SUH KJ, Keam B, Kim M, Park YS, et al
    Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.
    Clin Lung Cancer. 2015 Nov 30. pii: S1525-7304(15)00276.
    PubMed     Text format     Abstract available


  137. HATAYAMA Y, Nakamura T, Suzuki M, Azami Y, et al
    Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Nov 30. pii: S1525-7304(15)00277.
    PubMed     Text format     Abstract available


  138. LI P, Wang X, Liu Z, Liu H, et al
    Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Nov 22. pii: S1525-7304(15)00272.
    PubMed     Text format     Abstract available


  139. JEREMIC B, Casas F, Dubinsky P, Gomez-Caamano A, et al
    Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It.
    Clin Lung Cancer. 2015 Nov 11. pii: S1525-7304(15)00265.
    PubMed     Text format     Abstract available


  140. GIULIANI J, Bonetti A
    Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Nov 10. pii: S1525-7304(15)00263.
    PubMed     Text format    


    October 2015
  141. CHLEBOWSKI RT, Wakelee H, Pettinger M, Rohan T, et al
    Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
    Clin Lung Cancer. 2015 Oct 22. pii: S1525-7304(15)00236.
    PubMed     Text format     Abstract available


  142. SINGH N, Sarat Singh P, Aggarwal AN, Behera D, et al
    Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Clin Lung Cancer. 2015 Oct 22. pii: S1525-7304(15)00262.
    PubMed     Text format     Abstract available


  143. RADES D, Conde-Moreno AJ, Segedin B, Veninga T, et al
    A Prognostic Instrument to Estimate the Survival of Elderly Patients Irradiated for Metastatic Epidural Spinal Cord Compression From Lung Cancer.
    Clin Lung Cancer. 2015 Oct 21. pii: S1525-7304(15)00261.
    PubMed     Text format     Abstract available


  144. LARA PN JR, Moon J, Redman MW, Semrad TJ, et al
    Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.
    Clin Lung Cancer. 2015 Oct 20. pii: S1525-7304(15)00235.
    PubMed     Text format     Abstract available


  145. SWAMINATH A, Wright JR, Tsakiridis TK, Ung YC, et al
    A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Oct 9. pii: S1525-7304(15)00240.
    PubMed     Text format     Abstract available


  146. PALMA DA, Warner A, Louie AV, Senan S, et al
    Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-Analysis.
    Clin Lung Cancer. 2015 Oct 1. pii: S1525-7304(15)00239.
    PubMed     Text format     Abstract available


  147. SPRATT DE, Wu AJ, Adeseye V, Din SU, et al
    Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
    Clin Lung Cancer. 2015 Oct 1. pii: S1525-7304(15)00238.
    PubMed     Text format     Abstract available


    September 2015
  148. OEZKAN F, Khan AM, Hager T, Freitag L, et al
    OSNA: A Fast Molecular Test Based on CK19 mRNA Concentration for Assessment of EBUS-TBNA Samples in Lung Cancer Patients.
    Clin Lung Cancer. 2015 Sep 21. pii: S1525-7304(15)00219.
    PubMed     Text format     Abstract available


    August 2015
  149. BRACCI S, Valeriani M, Agolli L, De Sanctis V, et al
    Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
    Clin Lung Cancer. 2015 Aug 29. pii: S1525-7304(15)00218.
    PubMed     Text format     Abstract available


  150. KOCHER F, Lunger F, Seeber A, Amann A, et al
    Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis.
    Clin Lung Cancer. 2015 Aug 22. pii: S1525-7304(15)00217.
    PubMed     Text format     Abstract available


  151. TRAN TN, Selinger CI, Kohonen-Corish MR, McCaughan B, et al
    Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
    Clin Lung Cancer. 2015 Aug 18. pii: S1525-7304(15)00189.
    PubMed     Text format     Abstract available


  152. HOTTA K, Sasaki J, Saeki S, Takigawa N, et al
    Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.
    Clin Lung Cancer. 2015 Aug 18. pii: S1525-7304(15)00191.
    PubMed     Text format     Abstract available


  153. GOLDMAN JW, Shi P, Reck M, Paz-Ares L, et al
    Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mu
    Clin Lung Cancer. 2015 Aug 18. pii: S1525-7304(15)00190.
    PubMed     Text format     Abstract available


  154. SHAVERDIAN N, Veruttipong D, Wang J, Schaue D, et al
    Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Clin Lung Cancer. 2015 Aug 5. pii: S1525-7304(15)00187.
    PubMed     Text format     Abstract available


  155. LING DC, Hess CB, Chen AM, Daly ME, et al
    Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2015 Aug 3. pii: S1525-7304(15)00186.
    PubMed     Text format     Abstract available


  156. ONG LT, Dunphy M, Foster A, Woo KM, et al
    Prognostic Value of Preradiotherapy F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Aug 3. pii: S1525-7304(15)00184.
    PubMed     Text format     Abstract available


  157. SPEICHER PJ, Gu L, Gulack BC, Wang X, et al
    Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States.
    Clin Lung Cancer. 2015 Aug 3. pii: S1525-7304(15)00185.
    PubMed     Text format     Abstract available


    July 2015
  158. STINCHCOMBE TE, Borghaei H, Barker SS, Treat JA, et al
    Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Jul 30. pii: S1525-7304(15)00182.
    PubMed     Text format     Abstract available


  159. NARAYANAN V, Honce MJ, Mehrotra S, Camidge DR, et al
    Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non-Small-Cell Lung Cancer Patients Receiving Crizotinib.
    Clin Lung Cancer. 2015 Jul 30. pii: S1525-7304(15)00183.
    PubMed     Text format    


  160. NISHIO M, Goto K, Chikamori K, Hida T, et al
    Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Jul 29. pii: S1525-7304(15)00181.
    PubMed     Text format     Abstract available


    June 2015
  161. DE CASTRO J, Garcia R, Garrido P, Isla D, et al
    Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.
    Clin Lung Cancer. 2015 Jun 25. pii: S1525-7304(15)00166.
    PubMed     Text format     Abstract available


  162. LAM DC, Tam TC, Lau KM, Wong WM, et al
    Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer.
    Clin Lung Cancer. 2015 Jun 24. pii: S1525-7304(15)00165.
    PubMed     Text format     Abstract available


  163. MATTES MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, et al
    Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Jun 15. pii: S1525-7304(15)00163.
    PubMed     Text format     Abstract available


  164. ELLIS PM, Leighl NB, Hirsh V, Reaume MN, et al
    A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2015 Jun 2. pii: S1525-7304(15)00142.
    PubMed     Text format     Abstract available


  165. SCHUETTE W, Behringer D, Stoehlmacher J, Kollmeier J, et al
    CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non-Small-Cell Lung Cancer With Particular Regard to the KRAS Status.
    Clin Lung Cancer. 2015 Jun 2. pii: S1525-7304(15)00141.
    PubMed     Text format     Abstract available


    May 2015
  166. WANG H, Schabath MB, Liu Y, Berglund AE, et al
    Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.
    Clin Lung Cancer. 2015 May 27. pii: S1525-7304(15)00139.
    PubMed     Text format     Abstract available


  167. LEE SH, Lee EJ, Min KH, Hur GY, et al
    Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression.
    Clin Lung Cancer. 2015 May 18. pii: S1525-7304(15)00138.
    PubMed     Text format     Abstract available


  168. PETRIOLI R, Roviello G, Laera L, Luzzi L, et al
    Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.
    Clin Lung Cancer. 2015 May 18. pii: S1525-7304(15)00137.
    PubMed     Text format     Abstract available


  169. CARPENTIER O, Selvaggi L, Jegu J, Purohit A, et al
    Modern Treatments in Advanced Non-Small-Cell Lung Cancer: Temporal Trends and Effect on Survival. A French Population-Based Study.
    Clin Lung Cancer. 2015 May 13. pii: S1525-7304(15)00119.
    PubMed     Text format     Abstract available


  170. GANDARA DR, Mack PC, Bult C, Li T, et al
    Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
    Clin Lung Cancer. 2015;16:165-72.
    PubMed     Text format     Abstract available


    April 2015
  171. DE MARINIS F, Bria E, Baas P, Tiseo M, et al
    Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.
    Clin Lung Cancer. 2015 Apr 30. pii: S1525-7304(15)00118.
    PubMed     Text format     Abstract available


  172. GENESTRETI G, Tiseo M, Kenmotsu H, Kazushige W, et al
    Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Clin Lung Cancer. 2015 Apr 24. pii: S1525-7304(15)00089.
    PubMed     Text format     Abstract available


  173. YOO C, Yoon S, Lee DH, Park SI, et al
    Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Clin Lung Cancer. 2015 Apr 23. pii: S1525-7304(15)00087.
    PubMed     Text format     Abstract available


  174. LIU JT, Li WC, Gao S, Wang F, et al
    Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer Cells.
    Clin Lung Cancer. 2015 Apr 2. pii: S1525-7304(15)00081.
    PubMed     Text format     Abstract available


    March 2015
  175. COLACO RJ, Decker RH
    Stereotactic radiotherapy in the treatment of primary bronchial carcinoid tumor.
    Clin Lung Cancer. 2015;16:e11-4.
    PubMed     Text format    


  176. BUGES C, Carcereny E, Moran T, Cardona AF, et al
    Interstitial lung disease arising from erlotinib treatment in a Caucasian patient.
    Clin Lung Cancer. 2015;16:e1-3.
    PubMed     Text format    


  177. ZHAO N, Zheng SY, Yang JJ, Zhang XC, et al
    Lung adenocarcinoma harboring concomitant EGFR mutation and EML4-ALK fusion that benefits from three kinds of tyrosine kinase inhibitors: a case report and literature review.
    Clin Lung Cancer. 2015;16:e5-9.
    PubMed     Text format    


  178. YU S, Zhang B, Xiang C, Shu Y, et al
    Prospective assessment of pemetrexed or pemetrexed plus platinum in combination with gefitinib or erlotinib in patients with acquired resistance to gefitinib or erlotinib: a phase II exploratory and preliminary study.
    Clin Lung Cancer. 2015;16:121-7.
    PubMed     Text format     Abstract available


  179. LIAO BC, Shao YY, Chen HM, Shau WY, et al
    Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma.
    Clin Lung Cancer. 2015;16:137-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: